news

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. Acquires a Large Generic Product in a Sizable and Fast-Growing Therapeutic Area

Rameda, a leading Egyptian pharmaceutical company, announced today that it has signed an agreement to acquire a nonsteroidal anti-inflammatory analgesic molecule, marking the company’s largest molecule acquisition to date. The Molecule is a generic molecule in the anti-inflammatory therapeutic area, currently available in two concentrations, and...